The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Johnson & Johnson

NYSE: JNJ
Last

(U.S.) $124.53

Today's change-0.24 -0.19%
Updated July 28 11:02 AM EDT. Delayed by at least 15 minutes.
 

Johnson & Johnson

NYSE: JNJ
Last

(U.S.) $124.53

Today's change-0.24 -0.19%
Updated July 28 11:02 AM EDT. Delayed by at least 15 minutes.

Johnson & Johnson down (U.S.)$0.24

Johnson & Johnson is lower today, dropping (U.S.)$0.24 or 0.19% to (U.S.)$124.53. Shares have lost 0.50% over the last five days, but sit 1.22% below their 52-week high. This security has outperformed the S&P 500 by 22.53% during the last year.

Key company metrics

  • Open(U.S.) $124.98
  • Previous close(U.S.) $124.77
  • High(U.S.) $125.00
  • Low(U.S.) $124.41
  • Bid / Ask(U.S.) $124.53 / (U.S.) $124.54
  • YTD % change+21.23%
  • Volume1,127,811
  • Average volume (10-day)6,446,121
  • Average volume (1-month)7,432,740
  • Average volume (3-month)7,137,130
  • 52-week range(U.S.) $81.79 to (U.S.) $126.07
  • Beta0.57
  • Trailing P/E23.20×
  • P/E 1 year forward18.64×
  • Forward PEG2.84×
  • Indicated annual dividend(U.S.) $3.20
  • Dividend yield2.57%
  • Trailing EPS(U.S.) $5.37
Updated July 28 11:02 AM EDT. Delayed by at least 15 minutes.
S&P TSX0.19%Sector:HealthcareIndustry:Pharmaceuticals - Diversified

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJul 03, 201607/03/2016Apr 03, 201604/03/2016Jan 03, 201601/03/2016Sep 27, 201509/27/2015
Revenue18,48217,48217,81117,102
Total other revenue--------
Total revenue18,48217,48217,81117,102
Gross profit13,15312,17012,13811,878
Total cost of revenue5,3295,3125,6735,224
Total operating expense13,57812,18814,05312,980
Selling / general / administrative5,1764,6885,8915,081
Research & development2,2642,0132,8642,154
Depreciation / amortization--------
Interest expense (income), net operating----160123
Unusual expense (income)17013772310
Other operating expenses, total537-39-1,205412
Operating income4,9045,2943,7584,122
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax4,9045,2943,7584,122
Income after tax3,9974,4573,2153,358
Income tax, total907837543764
Net income3,9974,4573,2153,358
Total adjustments to net income--------
Net income before extra. items3,9974,4573,2153,358
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items3,9974,4573,2153,358
Inc. avail. to common incl. extra. items3,9974,4573,2153,358
Diluted net income3,9974,4573,2153,358
Dilution adjustment------0
Diluted weighted average shares2,7942,7982,8002,807
Diluted EPS excluding extraordinary itemsvalue per share1.431.591.151.20
Dividends per sharevalue per share--0.750.750.75
Diluted normalized EPSvalue per share1.661.651.571.20